Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Marion, Barends"'
Autor:
Kate Kolaczinski, Toby Leslie, Iftikhar Ali, Naeem Durrani, Sue Lee, Marion Barends, Khalid Beshir, Rosalynn Ord, Rachel Hallett, Mark Rowland
Publikováno v:
PLoS ONE, Vol 7, Iss 1, p e28957 (2012)
Antimalarial resistance has led to a global policy of artemisinin-based combination therapy. Despite growing resistance chloroquine (CQ) remained until recently the official first-line treatment for falciparum malaria in Pakistan, with sulfadoxine-py
Externí odkaz:
https://doaj.org/article/b70504a94a5a48209c82e7e8803aaec3
Autor:
Verena Ilona Carrara, Julien Zwang, Elizabeth A Ashley, Ric N Price, Kasia Stepniewska, Marion Barends, Alan Brockman, Tim Anderson, Rose McGready, Lucy Phaiphun, Stephane Proux, Michele van Vugt, Robert Hutagalung, Khin Maung Lwin, Aung Pyae Phyo, Piyanuch Preechapornkul, Mallika Imwong, Sasithon Pukrittayakamee, Pratap Singhasivanon, Nicholas J White, François Nosten
Publikováno v:
PLoS ONE, Vol 4, Iss 2, p e4551 (2009)
Artemisinin combination treatments (ACT) are recommended as first line treatment for falciparum malaria throughout the malaria affected world. We reviewed the efficacy of a 3-day regimen of mefloquine and artesunate regimen (MAS(3)), over a 13 year p
Externí odkaz:
https://doaj.org/article/a037634455494d65b713b0cb6e3a433d
Autor:
Rose McGready, Saw Oo Tan, Elizabeth A Ashley, Mupawjay Pimanpanarak, Jacher Viladpai-Nguen, Lucy Phaiphun, Katja Wüstefeld, Marion Barends, Natthapon Laochan, Lily Keereecharoen, Niklas Lindegardh, Pratap Singhasivanon, Nicholas J White, François Nosten
Publikováno v:
PLoS Medicine, Vol 5, Iss 12, p e253 (2008)
To date no comparative trials have been done, to our knowledge, of fixed-dose artemisinin combination therapies (ACTs) for the treatment of Plasmodium falciparum malaria in pregnancy. Evidence on the safety and efficacy of ACTs in pregnancy is needed
Externí odkaz:
https://doaj.org/article/059e6d457e504cdfa78dbba32543c7a1
Autor:
Shalini Nair, Becky Miller, Marion Barends, Anchalee Jaidee, Jigar Patel, Mayfong Mayxay, Paul Newton, François Nosten, Michael T Ferdig, Tim J C Anderson
Publikováno v:
PLoS Genetics, Vol 4, Iss 10, p e1000243 (2008)
Copy number polymorphism (CNP) is ubiquitous in eukaryotic genomes, but the degree to which this reflects the action of positive selection is poorly understood. The first gene in the Plasmodium folate biosynthesis pathway, GTP-cyclohydrolase I (gch1)
Externí odkaz:
https://doaj.org/article/efb60e45de6c415c8fc2f41919cdac8a
Autor:
Rossarin Suwanarusk, Bruce Russell, Marina Chavchich, Ferryanto Chalfein, Enny Kenangalem, Varakorn Kosaisavee, Budi Prasetyorini, Kim A Piera, Marion Barends, Alan Brockman, Usa Lek-Uthai, Nicholas M Anstey, Emiliana Tjitra, François Nosten, Qin Cheng, Ric N Price
Publikováno v:
PLoS ONE, Vol 2, Iss 10, p e1089 (2007)
Treatment failure of chloroquine for P. vivax infections has reached high levels in the eastern provinces of Indonesia, however, in vitro characterization of chloroquine resistance and its associated molecular profile have yet to be determined.Using
Externí odkaz:
https://doaj.org/article/a132ce1ed96a48f0aee3f34648af0065
Autor:
Melissa A, Rolfes, Doli, Goswami, Amina Tahia, Sharmeen, Sultana, Yeasmin, Nasrin, Parvin, Kamrun, Nahar, Mustafizur, Rahman, Marion, Barends, Dilruba, Ahmed, Mohammed Ziaur, Rahman, Joseph, Bresee, Stephen, Luby, Lawrence H, Moulton, Mathuram, Santosham, Alicia M, Fry, W Abdullah, Brooks
Publikováno v:
Vaccine
Highlights • There is limited data on efficacy of yearly influenza vaccination in children aged
Background Few trials have evaluated influenza vaccine efficacy (VE) in young children, a group particularly vulnerable to influenza complications.
Background Few trials have evaluated influenza vaccine efficacy (VE) in young children, a group particularly vulnerable to influenza complications.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7c938b2fbc00e1249cf2f89734d600e6
https://pubmed.ncbi.nlm.nih.gov/29100706
https://pubmed.ncbi.nlm.nih.gov/29100706
Autor:
Denae Nash, Shalini Nair, Anne-Catrin Uhlemann, François Nosten, Tim J. Anderson, Marion Barends, Daniel Sudimack, Sanjeev Krishna, Anchalee Jaidee
When selection is strong and beneficial alleles have a single origin, local reductions in genetic diversity are expected. However, when beneficial alleles have multiple origins or were segregating in the population prior to a change in selection regi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21e5d697832433e29e4888d32a34e68e
https://ora.ox.ac.uk/objects/uuid:fb574c07-adc7-4ac4-bfc8-cb1a0aeb02eb
https://ora.ox.ac.uk/objects/uuid:fb574c07-adc7-4ac4-bfc8-cb1a0aeb02eb
Autor:
Sue Lee, Naeem Durrani, Kate Kolaczinski, Khalid B. Beshir, Marion Barends, Rosalynn Ord, Rachel Hallett, Mark Rowland, Toby Leslie, Iftikhar Ali
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 1, p e28957 (2012)
PLoS ONE, Vol 7, Iss 1, p e28957 (2012)
INTRODUCTION: Antimalarial resistance has led to a global policy of artemisinin-based combination therapy. Despite growing resistance chloroquine (CQ) remained until recently the official first-line treatment for falciparum malaria in Pakistan, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e28dea8860dcd007b9cf77a1b2b75c69
https://doi.org/10.1371/journal.pone.0028957
https://doi.org/10.1371/journal.pone.0028957
Autor:
Kyaw L. Thwai, Nicholas J. White, François Nosten, Thra Slight, Robert Hutagalung, Lucy Phaiphun, Sornchai Looareesuwan, Elizabeth A. Ashley, Marion Barends, Rose McGready, Stephane Proux
Background. Dihydroartemisinin-piperaquine (DP) is a fixed-combination antimalarial drug increasingly deployed in Southeast Asia. The current regimen involves 4 doses given over 3 days. Simplificaiton of the dose regimen should facilitate treatment a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf7f0a48ee0f582ced55d49b73b09fdc
https://ora.ox.ac.uk/objects/uuid:5bfad33f-a4c3-4f1a-bef3-c59331368b1c
https://ora.ox.ac.uk/objects/uuid:5bfad33f-a4c3-4f1a-bef3-c59331368b1c
Autor:
Walter R. J. Taylor, Nantawan Wangseang, Wattana Leowattana, Khin Maung Lwin, Kyaw L. Thwai, Lucy Phaiphun, Nicholas J. White, Kasia Stepniewska, Stephane Proux, Piero Olliaro, Rose McGready, Wimon Nawamaneerat, Pratap Singhasivanon, Marion Barends, François Nosten, Win Htay Simon, Elizabeth A. Ashley
Summary Background Delivering drugs in a fixed combination is essential to the success of the strategy of artemisinin-based combination therapy. This prevents one drug being taken without the protection of the other, reducing the chance of emergence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b323af0ae779b7c5dc30dedf32fe8470
https://ora.ox.ac.uk/objects/uuid:3b34f4ed-9ff0-450a-9cb7-23303197519d
https://ora.ox.ac.uk/objects/uuid:3b34f4ed-9ff0-450a-9cb7-23303197519d